Non-Invasive Ventilation for Post-Extubation Respiratory Failure in High-Risk Patients

Abstract

Introduction: Extubation failure occurs in up to 20% of critically ill patients, increasing mortality. This review assesses the efficacy of non-invasive ventilation (NIV) immediately after extubation to prevent respiratory failure in high-risk populations.

Methods: A search of PubMed, Web of Science, and the Cochrane Database identified randomized trials comparing NIV versus conventional oxygen therapy or high-flow nasal cannula in adults at high risk for extubation failure (chronic obstructive pulmonary disease, heart failure, obesity hypoventilation syndrome). The primary outcome was reintubation within 72 hours.

Results: Twelve studies (3,102 patients) were included. NIV reduced reintubation rates by 34% compared to conventional oxygen but showed no difference versus high-flow nasal cannula alone. Mortality at 28 days did not differ significantly between groups. Patient discomfort and facial skin breakdown occurred in 14% of NIV recipients.

Discussion: NIV likely augments lung volume, reduces work of breathing, and improves gas exchange during the vulnerable post-extubation period. The similar performance to high-flow nasal cannula suggests that heated and humidified high-flow oxygen may offer comparable benefits with better tolerability. Heterogeneity in NIV interfaces and pressure settings complicates direct comparisons.

Conclusions: NIV effectively prevents reintubation in selected high-risk patients compared to conventional oxygen. High-flow nasal cannula represents a reasonable alternative with fewer adverse effects. Protocols should specify early NIV application at first signs of respiratory distress.